Medicare Enrolled
Dr. Jon Suleskey, D.O.
Urology Physician · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Suleskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suleskey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Suleskey
Dr. Jon Suleskey is an urology physician in Rochester Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Suleskey performed 7,007 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Suleskey received a total of $5,080 from 47 pharmaceutical and/or device companies across 250 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Suleskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in MI
$5,080 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,007
Medicare services
Top 7% in MI for urology physician
Not available
Unique patients (not deduplicated)
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
2,031 | $4 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,371 | $61 | $214 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
625 | $8 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
480 | $88 | $259 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
440 | $8 | $65 |
| PSA test (prostate cancer screening) | 385 | $18 | $121 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
231 | $173 | $768 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
196 | $132 | $352 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $111 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $42 | $119 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
116 | $18 | $121 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
114 | $3 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
114 | $68 | $270 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $134 | $799 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $61 | $194 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
55 | $92 | $266 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
50 | $44 | $303 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
49 | $76 | $636 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
45 | $19 | $121 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
33 | $147 | $2,990 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $26 | $121 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
29 | $19 | $424 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $126 | $817 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
25 | $75 | $2,952 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
25 | $80 | $424 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
23 | $25 | $200 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $316 | $4,950 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $10 | $61 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
18 | $252 | $924 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
11.5% medium
87.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,080
Total received (2018-2024)
Avg $726/year across 7 years
Top 33% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
250
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$976
2023
$1,279
2022
$612
2021
$718
2020
$204
2019
$666
2018
$625
Payments by company (2024)
PFIZER INC.
$133
Sumitomo Pharma America, Inc.
$117
PROGENICS PHARMACEUTICALS, INC.
$100
Teleflex LLC
$89
Janssen Biotech, Inc.
$75
Blue Earth Diagnostics Limited
$67
PROCEPT BioRobotics Corporation
$60
Valencia Technologies Corporation
$53
Bayer Healthcare Pharmaceuticals Inc.
$51
ABBVIE INC.
$50
Merck Sharp & Dohme LLC
$44
Cook Medical LLC
$39
ACCORD HEALTHCARE, INC.
$37
Boston Scientific Corporation
$35
AngioDynamics, Inc.
$27
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$994
Janssen Biotech, Inc.
$615
Sumitomo Pharma America, Inc.
$372
PFIZER INC.
$362
Myovant Sciences Inc.
$232
Coloplast Corp
$174
Endo Pharmaceuticals Inc.
$160
Bayer Healthcare Pharmaceuticals Inc.
$148
Teleflex LLC
$144
Merck Sharp & Dohme LLC
$112
Blue Earth Diagnostics Limited
$102
PROGENICS PHARMACEUTICALS, INC.
$100
ABBVIE INC.
$98
ACCORD HEALTHCARE, INC.
$90
Bayer HealthCare Pharmaceuticals Inc.
$85
TOLMAR Pharmaceuticals, Inc.
$82
Sunovion Pharmaceuticals Inc.
$78
Boston Scientific Corporation
$73
Amgen Inc.
$69
Allergan, Inc.
$63
180 Medical, Inc.
$61
PROCEPT BioRobotics Corporation
$60
C. R. Bard, Inc. & Subsidiaries
$59
BOSTON SCIENTIFIC CORPORATION
$59
Cook Medical LLC
$54
Valencia Technologies Corporation
$53
Baxter Healthcare
$49
AbbVie Inc.
$44
Bard Access Systems, Inc.
$42
ConvaTec Inc.
$41
Axonics, Inc.
$41
Dendreon Pharmaceuticals LLC
$39
Ambu Inc.
$31
Photocure Inc
$31
Mission Pharmacal Company
$29
AngioDynamics, Inc.
$27
Analogic Corporation
$27
Laborie Medical Technologies Corp.
$24
Myriad Genetic Laboratories, Inc.
$24
Rochester Medical Corporation
$24
Avadel Specialty Pharmaceuticals, LLC
$22
AMAG Pharmaceuticals, Inc.
$20
Retrophin, Inc.
$15
Travere Therapeutics, Inc.
$14
COLOPLAST CORP
$13
DENTSPLY IH Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · AVEED · AVYCAZ · Altis · Aquoral · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · COOK · COOK MEDICAL EXTRACTORS · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · Escape · FLOSEAL · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · INTRAROSA · KEYTRUDA · LUPRON DEPOT · LYNX · LoFric · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · RESONANCE · SPEEDICATH · TITAN · Thiola · UPHOLD LITE · UROLIFT · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · Xtandi · ZYTIGA · eCoin Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
156
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Suleskey is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Suleskey experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Suleskey performed 2,031 manual urinalysis with microscopic examination services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Suleskey receive payments from pharmaceutical companies?
Yes. Dr. Suleskey received a total of $5,080 from 47 companies across 250 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suleskey's costs compare to other urology physicians in Rochester Hills?
Dr. Suleskey's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suleskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rochester Hills
Browse urology physicians in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology